首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1515603

癌症惡病質市場，按治療方法、作用機制、應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Cancer Cachexia Market, By Therapeutics, By Mechanism of Action, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年06月04日 | 出版商:

AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2023年癌症惡病質市場規模為32.2832億美元，2024年至2032年複合年成長率為5.90%。

癌症惡病質市場-市場動態

癌症負擔上升推動市場需求

全球癌症負擔正在上升，需要根據國家和地區的優先事項修改癌症治療方法。根據國際癌症研究機構 (IARC) 2020 年 12 月的數據，全球五分之一的人會在一生中罹患癌症，其中十分之一的女性和八分之一的男性死於該疾病。世界衛生組織 2022 年 2 月發布的數據表明，每年約有 40 萬名兒童患有癌症，最常見的類型因國家而異。例如，子宮頸癌是 23 個國家中最常見的癌症。全球癌症負擔的增加也增加了癌症惡病質的盛行率，其特徵是蛋白質和能量負平衡、全身性發炎和無意識的去脂體重損失。癌症惡病質和癌症的盛行率不斷上升，以及新型癌症惡病質治療研發投資的增加，是推動市場成長的主要因素。

癌症惡病質市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 5.90% 左右的複合年成長率成長

根據治療細分，預計孕激素將在 2023 年顯示最大的市場佔有率

基於動作細分機制，食慾刺激器是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

癌症惡病質市場-細分分析：

全球癌症惡病質市場根據治療、作用機制、應用和區域進行廣泛細分。

根據治療方法，市場分為四類：黃體素、皮質類固醇、合併療法等。由於其成本較低且治療癌症惡病質的效率較高，黃體素細分市場將在 2023 年佔據主導市場。

依作用機制，市場大致分為兩類：食慾促效劑和減肥穩定劑。根據作用機制，食慾促效劑預計將在癌症惡病質市場中佔據主導地位並顯著成長。癌症患者經常會出現食慾不振和體重意外減輕的情況，這與體能狀態下降、對治療的反應和耐受性降低、生存率降低以及生活品質下降有關。因此，對於食慾下降的患者，擴大考慮使用食慾興奮劑。癌症惡病質盛行率的上升是推動市場成長的主要因素。

癌症惡病質市場 - 地理洞察

從地理來看，這個市場遍及歐洲、北美、拉丁美洲、亞太地區以及中東和非洲。這些區域根據參與國家進一步細分。由於癌症和癌症惡病質的高負擔、眾多藥品製造商的存在以及癌症患者護理的進步，預計北美將引領市場。根據 GLOBOCAN 2020 估計，墨西哥報告了約 195,499 例新癌症病例。此外，美國癌症協會預計 2022 年美國將診斷出約 190 萬例新癌症病例。

癌症惡病質市場-競爭格局：

癌症惡病質市場得到整合，只有少數幾家大公司在全球和地區開展業務。這些關鍵參與者主要專注於研發，開發治療癌症惡病質的高效新藥，導致越來越多的治療藥物等待批准和商業上市。截至 2022 年 10 月，clinicaltrials.gov 報告了 150 項已進行或正在進行的研究，旨在開發治療癌症惡病質的藥物。例如，2020 年 12 月，哥本哈根大學與紐西蘭大學醫院合作發起了一項研究，監測醫用大麻二酚對接受奧沙利鉑或紫杉醇化療的患者去脂體重（惡病質）的影響。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美癌症惡病質主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按治療方法）
- 北美市場規模與預測（按作用機制）
- 北美市場規模和預測（按應用）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲癌症惡病質主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模和預測（按治療方法）
- 歐洲市場規模與預測（按作用機制）
- 歐洲市場規模和預測（按應用）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區癌症惡病質主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模和預測（按治療方法）
- 亞太地區市場規模與預測（按作用機制）
- 亞太地區市場規模與預測（按應用）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲癌症惡病質主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按治療方法）
- 拉丁美洲市場規模與預測（按作用機制）
- 拉丁美洲市場規模與預測（按應用）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲癌症惡病質主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按治療方法）
- 中東和非洲市場規模和預測（按作用機制）
- 中東和非洲市場規模及預測（按應用）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 癌症惡病質產業

競爭儀表板
公司簡介
- Aeterna Zentaris
- Aphios Corporation
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Helsinn Group
- Merck KGaA
- Artelo Biosciences Inc.
- NGM Biopharmaceuticals
- Aveo Oncology
- Aavogen Inc.
- Green Cross Wellbeing Corporation
- Cannabics Pharmaceuticals Inc.
- TCI Peptide Therapeutics
- Fresenius Kabi
- Tetra Bio-Pharma
- Actimed Therapeutics
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV3357

REPORT HIGHLIGHT

Cancer Cachexia Market size was valued at USD 3,228.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

Cancer cachexia presents as a multifaceted metabolic syndrome frequently observed in patients with advanced stages of malignancy. Characterized by involuntary weight loss, skeletal muscle wasting, fatigue, and anorexia, this syndrome transcends the limitations of inadequate dietary intake. Underlying mechanisms encompass systemic inflammation, metabolic aberrations, and the host's response to tumor-derived factors. Despite advancements in oncological therapies, cancer cachexia remains a formidable challenge, significantly impacting both the treatment outcomes and quality of life for affected individuals.

Cancer Cachexia Market- Market Dynamics

Rising cancer burden to propel market demand

The global cancer burden is rising, necessitating the modification of cancer therapies according to national and regional priorities. According to the (IARC) International Agency for Research on Cancer in December 2020, 1 in 5 people globally will develop cancer during their lifetime, with 1 in 11 women and 1 in 8 men dying from the disease. Data from the WHO, published in February 2022, indicates that approximately 400,000 children develop cancer annually, with the most common types varying by country. For instance, cervical cancer is the most prevalent in 23 countries. The increasing global cancer burden also raises the prevalence of cancer cachexia, characterized by negative protein and energy balance, systemic inflammation, and involuntary loss of lean body mass. The growing prevalence of cancer cachexia, and cancer along with increased investment in R&D for novel cancer cachexia treatments, are major factors driving market growth.

Cancer Cachexia Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Therapeutics segmentation, progestogens were predicted to show maximum market share in the year 2023

Based on the mechanism of action segmentation, appetite stimulators were the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Cancer Cachexia Market- Segmentation Analysis:

The Global Cancer Cachexia Market is broadly segmented on the basis of Therapeutics, Mechanism of Action, Application, and Region.

The market is divided into four categories based on Therapeutics: progestogens, corticosteroids, combination therapies, and others. The progestogens segment held a dominant market share in 2023, due to their lower cost and high efficiency in treating cancer cachexia.

The market is broadly divided into two categories based on mechanism of action: Appetite Stimulators and Weight Loss Stabilizers. By mechanism of action, appetite stimulators are expected to dominate and grow significantly in the cancer cachexia market. Cancer patients often experience sort of appetite loss and unintended weight loss, which are linked to decreased performance status, reduced response and tolerance to treatment, decreased survival, and diminished quality of life. Therefore, the use of appetite stimulants is increasingly considered for patients with reduced appetite. The rising prevalence of cancer cachexia is a major factor driving the market's growth.

Cancer Cachexia Market- Geographical Insights

From a geographical perspective, this market extends across Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. These regions are further segmented based on the participating nations. North America is expected to lead the market, driven by the high burden of cancer and cancer cachexia, the presence of numerous drug manufacturers, and advancements in cancer patient care. According to GLOBOCAN 2020 estimates, Mexico reported around 195,499 new cancer cases. Additionally, the American Cancer Society projected approximately 1.9 million new cancer cases would be diagnosed in the United States in 2022.

Cancer Cachexia Market- Competitive Landscape:

The cancer cachexia market is consolidated, with only a few major companies operating globally and regionally. These key players are primarily focused on R&D to develop highly effective novel drugs for treating cancer cachexia, resulting in a growing pipeline of therapeutics awaiting approval and commercial launch. As of October 2022, clinicaltrials.gov reported 150 studies either conducted or ongoing to develop drugs for cancer cachexia. For instance, in December 2020, the University of Copenhagen, in collaboration with Zealand University Hospital, initiated a study to monitor the effect of the medical cannabidiol on the lean body mass (cachexia) in patients receiving Oxaliplatin- or Paclitaxel-based chemotherapy.

Recent Developments:

In January 2021, Helsinn Group and Ono Pharmaceutical Co. Ltd received approval in Japan to manufacture and market Adlumiz, a ghrelin receptor agonist for treating cancer cachexia in the patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, or colorectal cancer. Therefore, increasing research and development activities in the field are expected to drive market growth.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER CACHEXIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Aeterna Zentaris

Aphios Corporation

Bristol-Myers Squibb Company

Pfizer Inc.

Helsinn Group

Merck KGaA

Artelo Biosciences Inc.

NGM Biopharmaceuticals

Aveo Oncology

Aavogen Inc.

Green Cross Wellbeing Corporation

Cannabics Pharmaceuticals Inc.

TCI Peptide Therapeutics

Fresenius Kabi

Tetra Bio-Pharma

Actimed Therapeutics

Others

GLOBAL CANCER CACHEXIA MARKET, BY THERAPEUTICS - MARKET ANALYSIS, 2019 - 2032

Progestogens
Corticosteroids
Combination Therapy
Other Therapeutics

GLOBAL CANCER CACHEXIA MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032

Appetite Stimulators
Weight Loss Stabilizers

GLOBAL CANCER CACHEXIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

GLOBAL CANCER CACHEXIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Cancer Cachexia Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cancer Cachexia Market Snippet by Therapeutics
- 2.1.2. Cancer Cachexia Market Snippet by Mechanism of Action
- 2.1.3. Cancer Cachexia Market Snippet by Application
- 2.1.4. Cancer Cachexia Market Snippet by Country
- 2.1.5. Cancer Cachexia Market Snippet by Region
2.2. Competitive Insights

3. Cancer Cachexia Key Market Trends

3.1. Cancer Cachexia Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Cachexia Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Cachexia Market Opportunities
3.4. Cancer Cachexia Market Future Trends

4. Cancer Cachexia Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cancer Cachexia Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Cancer Cachexia Market Landscape

6.1. Cancer Cachexia Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cancer Cachexia Market - By Therapeutics

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapeutics, 2023 & 2032 (%)
- 7.1.2. Progestogens
- 7.1.3. Corticosteroids
- 7.1.4. Combination Therapy
- 7.1.5. Other Therapeutics

8. Cancer Cachexia Market - By Mechanism of Action

8.1. Overview
- 8.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
- 8.1.2. Appetite Stimulators
- 8.1.3. Weight Loss Stabilizers

9. Cancer Cachexia Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacy
- 9.1.3. Retail Pharmacy
- 9.1.4. Online Pharmacy

10. Cancer Cachexia Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Cancer Cachexia Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Cancer Cachexia Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Cancer Cachexia Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Cancer Cachexia Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Cancer Cachexia Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cancer Cachexia Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Aeterna Zentaris
- 11.2.2. Aphios Corporation
- 11.2.3. Bristol-Myers Squibb Company
- 11.2.4. Pfizer Inc.
- 11.2.5. Helsinn Group
- 11.2.6. Merck KGaA
- 11.2.7. Artelo Biosciences Inc.
- 11.2.8. NGM Biopharmaceuticals
- 11.2.9. Aveo Oncology
- 11.2.10. Aavogen Inc.
- 11.2.11. Green Cross Wellbeing Corporation
- 11.2.12. Cannabics Pharmaceuticals Inc.
- 11.2.13. TCI Peptide Therapeutics
- 11.2.14. Fresenius Kabi
- 11.2.15. Tetra Bio-Pharma
- 11.2.16. Actimed Therapeutics
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Cancer Cachexia Market: Therapeutics Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Therapeutics
TABLE Global Cancer Cachexia Market, by Therapeutics 2019-2032 (USD Million)
TABLE Cancer Cachexia Market: Mechanism of Action Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Mechanism of Action
TABLE Global Cancer Cachexia Market, by Mechanism of Action 2019-2032 (USD Million)
TABLE Cancer Cachexia Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Cancer Cachexia Market, by Application 2019-2032 (USD Million)
TABLE Cancer Cachexia Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Cancer Cachexia Market, by Region 2019-2032 (USD Million)
TABLE North America Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
TABLE North America Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
TABLE North America Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
TABLE North America Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
TABLE Europe Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
TABLE Europe Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
TABLE Europe Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
TABLE Europe Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
TABLE Asia Pacific Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
TABLE Asia Pacific Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
TABLE Latin America Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
TABLE Latin America Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
TABLE Middle East and Africa Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
TABLE Middle East and Africa Cancer Cachexia Market, by Application, 2019-2032 (USD Million)

List of Figures

FIGURE Cancer Cachexia Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2023
FIGURE Therapeutics segment market share analysis, 2023 & 2032
FIGURE Therapeutics segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mechanism of Action segment market share analysis, 2023 & 2032
FIGURE Mechanism of Action segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Application segment market share analysis, 2023 & 2032
FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2023 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America Cancer Cachexia Market share and leading players, 2023
FIGURE Europe Cancer Cachexia Market share and leading players, 2023
FIGURE Asia Pacific Cancer Cachexia Market share and leading players, 2023
FIGURE Latin America Cancer Cachexia Market share and leading players, 2023
FIGURE Middle East and Africa Cancer Cachexia Market share and leading players, 2023
FIGURE North America market share analysis by country, 2023
FIGURE U.S. Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe Cancer Cachexia Market share analysis by country, 2023
FIGURE Germany Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific Cancer Cachexia Market share analysis by country, 2023
FIGURE India Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Philippines Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Cancer Cachexia Market share analysis by country, 2023
FIGURE Brazil Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Cancer Cachexia Market share analysis by country, 2023
FIGURE Saudi Arabia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)